Q4 2019 13F Holders as of 12/31/2019
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
49.8M
-
Number of holders
-
101
-
Total 13F shares, excl. options
-
44.8M
-
Shares change
-
+4.49M
-
Total reported value, excl. options
-
$1.16B
-
Value change
-
+$118M
-
Put/Call ratio
-
2.28
-
Number of buys
-
57
-
Number of sells
-
-31
-
Price
-
$25.89
Significant Holders of Theravance Biopharma, Inc. - Common Stock (TBPH) as of Q4 2019
112 filings reported holding TBPH - Theravance Biopharma, Inc. - Common Stock as of Q4 2019.
Theravance Biopharma, Inc. - Common Stock (TBPH) has 101 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 44.8M shares
of 49.8M outstanding shares and own 90.01% of the company stock.
Largest 10 shareholders include BAUPOST GROUP LLC/MA (9.31M shares), FMR LLC (8.46M shares), Link Fund Solutions Ltd (5.25M shares), VANGUARD GROUP INC (4M shares), BlackRock Inc. (3.83M shares), WELLINGTON MANAGEMENT GROUP LLP (3.18M shares), NORGES BANK (1.08M shares), STATE STREET CORP (960K shares), Chescapmanager LLC (949K shares), and Rock Springs Capital Management LP (655K shares).
This table shows the top 101 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.